Rituximab with high-dose methotrexate in primary central nervous system lymphoma.
Am J Hematol
; 90(12): 1149-54, 2015 Dec.
Article
in En
| MEDLINE
| ID: mdl-26414492
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Methotrexate
/
Central Nervous System Neoplasms
/
Rituximab
/
Antimetabolites, Antineoplastic
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Hematol
Year:
2015
Type:
Article
Affiliation country:
Canada